bradykinin, leu(8)-des-arg(9)- has been researched along with Cognition Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calixto, JB; Campos, MM; Duarte, FS; Medeiros, R; Pandolfo, P; Passos, GF; Pesquero, JB; Prediger, RD; Takahashi, RN | 1 |
1 other study(ies) available for bradykinin, leu(8)-des-arg(9)- and Cognition Disorders
| Article | Year |
|---|---|
Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Behavior, Animal; Bradykinin; Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Cerebral Cortex; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Hippocampus; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Reaction Time; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Time Factors | 2008 |